LEQEMBI® (lecanemab-irmb) as an Option for Early Intervention in Alzheimer’s Disease presented by Dr. Brent Berry

Excited for the Spring Primary Care Conference, but don't want to wait until May?  Here is your chance to preview one of our presenters, Dr. Brent Berry!

Dr. Berry is an attending physician with the Division of Neurology at North Memorial Medical Center, Minneapolis
and the Clinic of Neurology in Minneapolis and Maple Grove, Minnesota.  He has graciously accepted to present at our spring conference and has given us the opportunity to hear and visit with him virtually prior to the conference.  

LEQEMBI® (lecanemab-irmb) as an Option
for Early Intervention in Alzheimer’s Disease

This program will:
Provide expert insights on the label for LEQEMBI® for the treatment of MCI due to AD and mild AD dementia and highlight key 
considerations for clinical practice including:
• Identifying appropriate patients for treatment with LEQEMBI
• Key efficacy and safety data from the Clarity AD study
• Best practices for ARIA screening and management
• Navigating the steps from diagnosis to treatment with LEQEMBI

There is no CME with this event.  Please RSVP to Stacy Gleason, Senior Neurology Account Specialist Alzheimer’s Division, Stacy_gleason@eisai.com